Review



antiviral compounds hep 2  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC antiviral compounds hep 2
    Antiviral Compounds Hep 2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 3927 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/compound+2/HEp-2/pm42012186-201-3-6
    Average 99 stars, based on 3927 article reviews
    antiviral compounds hep 2 - by Bioz Stars, 2026-11
    99/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: A ciliated epithelial cell line as a model for respiratory syncytial virus research.
    Article Snippet: .. HEp- 2 cell line (ATCC Cat# CCL- 23, RRID: CVCL_1906) was cultured in Eagle’s minimum essential medium (MEM, Gibcotm) supplemented with 10% (v/v) FCS (ref 10270–106, Gibcotm) and 1% penicillin- streptomycin (PS, 5,000 U ml−1, ref 15070–063, Gibcotm, Fisher Scientific). ..

    other:

    Article Title: The actin-binding protein drebrin interacts with the respiratory syncytial virus matrix protein and promotes virus particle release
    Article Snippet: HEp-2 cells (ATCC, CCl-23) were maintained in Eagle’s minimum essential medium (MEM) supplemented with 10% heat-inactivated foetal bovine serum (FBS) and with 1% penicillin- streptomycin solution 5000 U/ml.

    Infection:

    Article Title: Combined Effects of Chlamydia pneumoniae Infection and Hypoxia on Glial Metabolism and Alzheimer's Disease-Related Pathways.
    Article Snippet: .. Cells were infected with Chlamydia pneumoniae strain AR-39 (ATCC 53592), originally isolated from a human throat and propagated in HEp-2 cells (ATCC CCL-23) before expansion in BEAS-2B cells. ..

    Article Title: Transplacental transfer of maternal binding and neutralizing antibodies against respiratory syncytial virus - An assay specific comparison.
    Article Snippet: Background: Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections in young children.. Maternal antibodies can protect infants against RSV in the first months of life.. Assessing antibody transfer efficiency by comparing infant to maternal antibody titers (C/M) is important for determining timing for maternal vaccination.

    Isolation:

    Article Title: Combined Effects of Chlamydia pneumoniae Infection and Hypoxia on Glial Metabolism and Alzheimer's Disease-Related Pathways.
    Article Snippet: .. Cells were infected with Chlamydia pneumoniae strain AR-39 (ATCC 53592), originally isolated from a human throat and propagated in HEp-2 cells (ATCC CCL-23) before expansion in BEAS-2B cells. ..

    Plasmid Preparation:

    Article Title: Multidrug resistance and lipopolysaccharide remodeling associated with mcr-1 acquisition in Shiga toxin-producing Escherichia coli .
    Article Snippet: .. Acquisition of the mcr-1-harboring plasmid in E. coli O157:H7 ATCC 43894 increased adhesion to HEp-2 epithelial cells but reduced swimming motility, biofilm formation, and Galleria mellonella mortality. ..

    Chloramphenicol Acetyltransferase Assay:

    Article Title: RSV & rhinovirus coinfection order dictates outcome via type III interferon-mediated interference in infant respiratory epithelium
    Article Snippet: .. H1 HeLa cell line (ATCC; CAT CRL-1958) and HEp-2 cell line (ATCC) were grown in minimum essential media (MEM) with 10% fetal bovine serum (FBS) (Corning; CAT# 35-015-CV) and supplemented with 1% L-glutamine (Gibco; CAT# 25030-081) and 1% antibiotic/antimycotic (SIGMA-ALDRICH; CAT# A5955). .. Human rhinovirus A-16 (RV-A16) strain 11757 purchased from ATCC (CAT# VR-283) was expanded three times in H1 HeLa cells to generate stock viral pools at a consistent and low passage number.



    Similar Products

    94
    TargetMol compound 2
    Compound 2, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/compound+2/Compound+2/pm42413585-63-3-8
    Average 94 stars, based on 1 article reviews
    compound 2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    InvivoGen diabzi compound 3
    Diabzi Compound 3, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/compound+2/diABZI/pmc13561860-441-24-27
    Average 99 stars, based on 1 article reviews
    diabzi compound 3 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    94
    TargetMol hit compounds 2 methoxycinnamaldehyde
    Hit Compounds 2 Methoxycinnamaldehyde, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/compound+2/hnps-PLA+Inhibitor/10__1038_slash_s41467___026___76252___6-156-20-45
    Average 94 stars, based on 1 article reviews
    hit compounds 2 methoxycinnamaldehyde - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    InvivoGen diabzi compound 3 tlrl diabzi
    Diabzi Compound 3 Tlrl Diabzi, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/compound+2/diABZI/pm42483932-438-0-7
    Average 99 stars, based on 1 article reviews
    diabzi compound 3 tlrl diabzi - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    86
    Shionogi 2 piperazino pyrimidine compound
    2 Piperazino Pyrimidine Compound, supplied by Shionogi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/compound+2/2+compound+piperazino+pyrimidine/pmc13123328-6-11-6
    Average 86 stars, based on 1 article reviews
    2 piperazino pyrimidine compound - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    TargetMol compound c
    Compound C, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/compound+2/2-Deoxy-D-glucose/pm42126735-50-15-19
    Average 94 stars, based on 1 article reviews
    compound c - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Molecular Dynamics Inc compound 58 vegfr 2 complex
    Compound 58 Vegfr 2 Complex, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/compound+2/2+58+complex+compound+vegfr/pm42319585-439-5-0
    Average 86 stars, based on 1 article reviews
    compound 58 vegfr 2 complex - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Molecular Dynamics Inc compounds 2
    Compounds 2, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/compound+2/2+compounds/pm42280258-132-21-13
    Average 86 stars, based on 1 article reviews
    compounds 2 - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Pfizer Inc compound r 3 amino 1 hydroxy 3 4 dihydroquinolin 2 1h one pf 04859989
    (A) Schematic representation of major tryptophan (Trp)-derived metabolic pathways, including the kynurenine pathway (center), the indole-3-pyruvic acid (IPA)–indole-3-acetic acid (IAA) pathway, and the tryptamine– serotonin–melatonin branch (top). Solid, dashed, and double boxes indicate metabolites reported in animals, plants, or both, respectively. Enzymes are indicated at each step: IDO1/IDO2 (indoleamine 2,3-dioxygenase), TDO (tryptophan 2,3-dioxygenase), AFMID (arylformamidase), KAT (kynurenine aminotransferase), TDC (tryptophan decarboxylase), TAA1/TAR (tryptophan aminotransferase), KYNU (kynureninase), KMO (kynurenine 3-monooxygenase), HAAO (3-hydroxyanthranilate 3,4-dioxygenase), ACMSD (α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase), and QPRT (quinolinate phosphoribosyltransferase). Inhibitor targets are indicated at the corresponding steps: JM6 and RO 61-8048 inhibit KMO, <t>and</t> <t>PF-04859989</t> inhibits KAT. (B) Chemical structures of the kynurenine pathway metabolites quantified in this study: kynurenine, kynurenic acid (KYNA), and 3-hydroxyanthranilic acid (3-HAA). (C) Chemical structures of the inhibitors used in this study. Core structural differences between JM6 and RO 61-8048 are highlighted in red.
    Compound R 3 Amino 1 Hydroxy 3 4 Dihydroquinolin 2 1h One Pf 04859989, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/compound+2/05+1+1+1+10+11+11s+12+12r+13+13+2+2+2+3+3+3+4+4+4+5+6+7+7+8+fluoro+fluorophenyl+methyl+one+tetraen+triazatricyclo+triazol+trideca+yl/bio_rxiv__64898__2026__05__18__726114-26-1-12
    Average 86 stars, based on 1 article reviews
    compound r 3 amino 1 hydroxy 3 4 dihydroquinolin 2 1h one pf 04859989 - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    MedChemExpress compound golgicide a 2
    A UMAP visualization comparing raw gene expression profiles with BioGDR-derived embeddings, where sensitivity is defined by the top 5% predicted responses. B Dose-response curve of <t>Golgicide</t> <t>A-2</t> in T84 colorectal cancer cells. C Systematic performance comparison via SCC between experimental sensitivity measurements and predictions from multiple approaches: ALDH1B1 expression levels, BioGDR predictions, and baseline model outputs. D Target recognition capability demonstrated by ALDH1B1’s mean attention ranking for Golgicide A-2 relative to the complete PRISM drug set. E Pathway-level mechanistic analysis highlighting ALDH1B1-involved ARGININE AND PROLINE METABOLISM pathway (orange). F Fine-grained gene attention analysis within the arginine and proline metabolism pathway, with attention scores indicated by color intensity.
    Compound Golgicide A 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/compound+2/Golgicide+A-2/pmc13396495-397-1-7
    Average 94 stars, based on 1 article reviews
    compound golgicide a 2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    (A) Schematic representation of major tryptophan (Trp)-derived metabolic pathways, including the kynurenine pathway (center), the indole-3-pyruvic acid (IPA)–indole-3-acetic acid (IAA) pathway, and the tryptamine– serotonin–melatonin branch (top). Solid, dashed, and double boxes indicate metabolites reported in animals, plants, or both, respectively. Enzymes are indicated at each step: IDO1/IDO2 (indoleamine 2,3-dioxygenase), TDO (tryptophan 2,3-dioxygenase), AFMID (arylformamidase), KAT (kynurenine aminotransferase), TDC (tryptophan decarboxylase), TAA1/TAR (tryptophan aminotransferase), KYNU (kynureninase), KMO (kynurenine 3-monooxygenase), HAAO (3-hydroxyanthranilate 3,4-dioxygenase), ACMSD (α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase), and QPRT (quinolinate phosphoribosyltransferase). Inhibitor targets are indicated at the corresponding steps: JM6 and RO 61-8048 inhibit KMO, and PF-04859989 inhibits KAT. (B) Chemical structures of the kynurenine pathway metabolites quantified in this study: kynurenine, kynurenic acid (KYNA), and 3-hydroxyanthranilic acid (3-HAA). (C) Chemical structures of the inhibitors used in this study. Core structural differences between JM6 and RO 61-8048 are highlighted in red.

    Journal: bioRxiv

    Article Title: Auxin is metabolized through kynurenine in Hypericum perforatum L

    doi: 10.64898/2026.05.18.726114

    Figure Lengend Snippet: (A) Schematic representation of major tryptophan (Trp)-derived metabolic pathways, including the kynurenine pathway (center), the indole-3-pyruvic acid (IPA)–indole-3-acetic acid (IAA) pathway, and the tryptamine– serotonin–melatonin branch (top). Solid, dashed, and double boxes indicate metabolites reported in animals, plants, or both, respectively. Enzymes are indicated at each step: IDO1/IDO2 (indoleamine 2,3-dioxygenase), TDO (tryptophan 2,3-dioxygenase), AFMID (arylformamidase), KAT (kynurenine aminotransferase), TDC (tryptophan decarboxylase), TAA1/TAR (tryptophan aminotransferase), KYNU (kynureninase), KMO (kynurenine 3-monooxygenase), HAAO (3-hydroxyanthranilate 3,4-dioxygenase), ACMSD (α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase), and QPRT (quinolinate phosphoribosyltransferase). Inhibitor targets are indicated at the corresponding steps: JM6 and RO 61-8048 inhibit KMO, and PF-04859989 inhibits KAT. (B) Chemical structures of the kynurenine pathway metabolites quantified in this study: kynurenine, kynurenic acid (KYNA), and 3-hydroxyanthranilic acid (3-HAA). (C) Chemical structures of the inhibitors used in this study. Core structural differences between JM6 and RO 61-8048 are highlighted in red.

    Article Snippet: The compound (R)-3-amino-1-hydroxy-3,4-dihydroquinolin-2(1H)-one (PF-04859989) was identified by a high-throughput screen of the Pfizer compound library as a high-affinity inhibitor of human kynurenine aminotransferase (KAT; ).

    Techniques: Derivative Assay

    ( A) Representative images of explants cultured on MSO (control), kynurenine (KYN), indole-3-acetic acid (IAA), and IAA combined with inhibitors (IAA + JM6, IAA + PF-04859989 [PF], and IAA + RO 61-8048 [RO]). Scale bar = 1 cm (B) Rooting frequency, (C) internodal length (cm per node), (D) root number, and (E) maximum root length (cm) of explants under each treatment. For rooting frequency (B), bars represent mean proportion rooted ± SE. For (C–E), boxplots represent median (center line), interquartile range (box), and range (whiskers). Differences relative to the MSO control were evaluated using Dunnett-adjusted contrasts (p < 0.05; n = 12–18 per treatment).

    Journal: bioRxiv

    Article Title: Auxin is metabolized through kynurenine in Hypericum perforatum L

    doi: 10.64898/2026.05.18.726114

    Figure Lengend Snippet: ( A) Representative images of explants cultured on MSO (control), kynurenine (KYN), indole-3-acetic acid (IAA), and IAA combined with inhibitors (IAA + JM6, IAA + PF-04859989 [PF], and IAA + RO 61-8048 [RO]). Scale bar = 1 cm (B) Rooting frequency, (C) internodal length (cm per node), (D) root number, and (E) maximum root length (cm) of explants under each treatment. For rooting frequency (B), bars represent mean proportion rooted ± SE. For (C–E), boxplots represent median (center line), interquartile range (box), and range (whiskers). Differences relative to the MSO control were evaluated using Dunnett-adjusted contrasts (p < 0.05; n = 12–18 per treatment).

    Article Snippet: The compound (R)-3-amino-1-hydroxy-3,4-dihydroquinolin-2(1H)-one (PF-04859989) was identified by a high-throughput screen of the Pfizer compound library as a high-affinity inhibitor of human kynurenine aminotransferase (KAT; ).

    Techniques: Cell Culture, Control

    (A–C) Representative extracted ion chromatograms (EICs) of PF-04859989 (A), RO 61-8048 (B), and JM6 (KMO inhibitor II) (C) detected in plant tissue by LC–HRMS. Each panel shows the precursor ion trace at the expected m/z and retention time. (D–F) Relative abundance of PF (D), RO (E), and JM6 (F) in roots and shoots following treatment with MSO (control), inhibitor alone, or IAA + inhibitor. Peak areas are shown as log□□-transformed values. Boxplots represent median (center line), interquartile range (box), and range (whiskers). Signals corresponding to each inhibitor were observed in treated tissues and were not detected in MSO controls. Detection was also observed in IAA co-application treatments.

    Journal: bioRxiv

    Article Title: Auxin is metabolized through kynurenine in Hypericum perforatum L

    doi: 10.64898/2026.05.18.726114

    Figure Lengend Snippet: (A–C) Representative extracted ion chromatograms (EICs) of PF-04859989 (A), RO 61-8048 (B), and JM6 (KMO inhibitor II) (C) detected in plant tissue by LC–HRMS. Each panel shows the precursor ion trace at the expected m/z and retention time. (D–F) Relative abundance of PF (D), RO (E), and JM6 (F) in roots and shoots following treatment with MSO (control), inhibitor alone, or IAA + inhibitor. Peak areas are shown as log□□-transformed values. Boxplots represent median (center line), interquartile range (box), and range (whiskers). Signals corresponding to each inhibitor were observed in treated tissues and were not detected in MSO controls. Detection was also observed in IAA co-application treatments.

    Article Snippet: The compound (R)-3-amino-1-hydroxy-3,4-dihydroquinolin-2(1H)-one (PF-04859989) was identified by a high-throughput screen of the Pfizer compound library as a high-affinity inhibitor of human kynurenine aminotransferase (KAT; ).

    Techniques: Control, Transformation Assay

    Concentrations of (A, D) kynurenic acid (KYNA), (B, E) kynurenine (KYN), and (C, F) 3-hydroxyanthranilic acid (3-HAA) in shoots (A–C) and roots (D–F) of explants cultured on MSO (control), IAA, or IAA combined with kynurenine pathway inhibitors (IAA + JM6, IAA + PF-04859989, and IAA + RO 61-8048). Concentrations are shown as log□□ (ng g −1 FW). Boxplots represent median (center line), interquartile range (box), and range (whiskers). For shoots (A–C), different letters indicate significant differences among treatments (one-way ANOVA followed by Tukey’s HSD, p < 0.05; n = 3). For roots (D–F), differences relative to the MSO control were evaluated using Dunnett-adjusted contrasts (p < 0.05; n = 3).

    Journal: bioRxiv

    Article Title: Auxin is metabolized through kynurenine in Hypericum perforatum L

    doi: 10.64898/2026.05.18.726114

    Figure Lengend Snippet: Concentrations of (A, D) kynurenic acid (KYNA), (B, E) kynurenine (KYN), and (C, F) 3-hydroxyanthranilic acid (3-HAA) in shoots (A–C) and roots (D–F) of explants cultured on MSO (control), IAA, or IAA combined with kynurenine pathway inhibitors (IAA + JM6, IAA + PF-04859989, and IAA + RO 61-8048). Concentrations are shown as log□□ (ng g −1 FW). Boxplots represent median (center line), interquartile range (box), and range (whiskers). For shoots (A–C), different letters indicate significant differences among treatments (one-way ANOVA followed by Tukey’s HSD, p < 0.05; n = 3). For roots (D–F), differences relative to the MSO control were evaluated using Dunnett-adjusted contrasts (p < 0.05; n = 3).

    Article Snippet: The compound (R)-3-amino-1-hydroxy-3,4-dihydroquinolin-2(1H)-one (PF-04859989) was identified by a high-throughput screen of the Pfizer compound library as a high-affinity inhibitor of human kynurenine aminotransferase (KAT; ).

    Techniques: Cell Culture, Control

    Indole-3-acetic acid (IAA) is primarily synthesized from tryptophan through the indole-3-pyruvate (IPyA) pathway via tryptophan aminotransferase (TAA) and YUCCA flavin monooxygenase (YUC). Free IAA may be regulated through conjugation, catabolism, oxidative transformation and through feedback effects on tryptophan-derived metabolism. Kynurenine pathway metabolism proceeds through N-formyl-kynurenine and kynurenine, which occupies a central branch point between kynurenic acid formation via kynurenine aminotransferase (KAT) and downstream oxidative metabolism toward 3-hydroxyanthranilic acid (3-HAA) via kynurenine monooxygenase (KMO). Reactive oxygen species (ROS), temperature, drought, iron, and Fe 2+ are shown as potential stress and redox inputs that may influence auxin and kynurenine-associated metabolism. The pharmacological inhibitors used in this study are shown at their proposed targets: PF-04859989 at KAT, and RO-61-8048 and JM6 at kynurenine monooxygenase (KMO). Dashed arrows indicate proposed interactions linking auxin catabolism or oxidative transformation with kynurenine-associated metabolite accumulation and potential feedback on tryptophan-dependent auxin biosynthesis.

    Journal: bioRxiv

    Article Title: Auxin is metabolized through kynurenine in Hypericum perforatum L

    doi: 10.64898/2026.05.18.726114

    Figure Lengend Snippet: Indole-3-acetic acid (IAA) is primarily synthesized from tryptophan through the indole-3-pyruvate (IPyA) pathway via tryptophan aminotransferase (TAA) and YUCCA flavin monooxygenase (YUC). Free IAA may be regulated through conjugation, catabolism, oxidative transformation and through feedback effects on tryptophan-derived metabolism. Kynurenine pathway metabolism proceeds through N-formyl-kynurenine and kynurenine, which occupies a central branch point between kynurenic acid formation via kynurenine aminotransferase (KAT) and downstream oxidative metabolism toward 3-hydroxyanthranilic acid (3-HAA) via kynurenine monooxygenase (KMO). Reactive oxygen species (ROS), temperature, drought, iron, and Fe 2+ are shown as potential stress and redox inputs that may influence auxin and kynurenine-associated metabolism. The pharmacological inhibitors used in this study are shown at their proposed targets: PF-04859989 at KAT, and RO-61-8048 and JM6 at kynurenine monooxygenase (KMO). Dashed arrows indicate proposed interactions linking auxin catabolism or oxidative transformation with kynurenine-associated metabolite accumulation and potential feedback on tryptophan-dependent auxin biosynthesis.

    Article Snippet: The compound (R)-3-amino-1-hydroxy-3,4-dihydroquinolin-2(1H)-one (PF-04859989) was identified by a high-throughput screen of the Pfizer compound library as a high-affinity inhibitor of human kynurenine aminotransferase (KAT; ).

    Techniques: Synthesized, Conjugation Assay, Transformation Assay, Derivative Assay

    A UMAP visualization comparing raw gene expression profiles with BioGDR-derived embeddings, where sensitivity is defined by the top 5% predicted responses. B Dose-response curve of Golgicide A-2 in T84 colorectal cancer cells. C Systematic performance comparison via SCC between experimental sensitivity measurements and predictions from multiple approaches: ALDH1B1 expression levels, BioGDR predictions, and baseline model outputs. D Target recognition capability demonstrated by ALDH1B1’s mean attention ranking for Golgicide A-2 relative to the complete PRISM drug set. E Pathway-level mechanistic analysis highlighting ALDH1B1-involved ARGININE AND PROLINE METABOLISM pathway (orange). F Fine-grained gene attention analysis within the arginine and proline metabolism pathway, with attention scores indicated by color intensity.

    Journal: NPJ Digital Medicine

    Article Title: Multimodal interpretable deep learning for transcriptome-informed precision oncology and drug mechanism analysis

    doi: 10.1038/s41746-026-02735-x

    Figure Lengend Snippet: A UMAP visualization comparing raw gene expression profiles with BioGDR-derived embeddings, where sensitivity is defined by the top 5% predicted responses. B Dose-response curve of Golgicide A-2 in T84 colorectal cancer cells. C Systematic performance comparison via SCC between experimental sensitivity measurements and predictions from multiple approaches: ALDH1B1 expression levels, BioGDR predictions, and baseline model outputs. D Target recognition capability demonstrated by ALDH1B1’s mean attention ranking for Golgicide A-2 relative to the complete PRISM drug set. E Pathway-level mechanistic analysis highlighting ALDH1B1-involved ARGININE AND PROLINE METABOLISM pathway (orange). F Fine-grained gene attention analysis within the arginine and proline metabolism pathway, with attention scores indicated by color intensity.

    Article Snippet: The compound Golgicide A-2 was purchased from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: Gene Expression, Derivative Assay, Comparison, Expressing